A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22)

被引:6
作者
Kawakami, Keiki [1 ,2 ]
Nishii, Kazuhiro [3 ]
Hyou, Ryuu [3 ]
Watanabe, Yasuyuki [2 ]
Nakao, Makoto [2 ]
Mitani, Hidetsugu [2 ]
Murata, Tetsuya [4 ]
Monma, Fumihiko [3 ]
Yamamori, Shunji [5 ]
Hosokai, Noboru [5 ]
Miura, Ikuo [6 ]
机构
[1] Suzuka Gen Hosp, Div Hematol, Suzuka, Mie, Japan
[2] Suzuka Gen Hosp, Div Hematol & Oncol, Suzuka, Mie, Japan
[3] Mie Univ, Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan
[4] Suzuka Gen Hosp, Div Pathol & Clin Labs, Suzuka, Mie, Japan
[5] Mitsubishi Kagaku Bioclin Labs Inc, Tokyo, Japan
[6] St Marianne Univ, Sch Med, Dept Hematol & Oncol, Kawasaki, Kanagawa, Japan
关键词
t(8; 21)(q22; q22); masked type translocation; acute myeloblastic leukemia;
D O I
10.1007/s12185-007-0010-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We encountered a case of acute myeloblastic leukemia (AML), with extramedullary leukemia (EML) and a masked type of the variant translocation t(8;21)(q22;q22). Morphologically, the AML M2 subtype according to the French-American-British (FAB) classification was present. Phenotypically, leukemic cells were negative for CD19 and positive for CD56. Clinically, the case showed chemo-refractoriness and a poor outcome. The initial karyotypic interpretation was t(8;9)(q22;q34) on G-banding. Multiplex-fluorescence in situ hybridization (multiplex-FISH) analysis revealed a three-way translocation involving chromosomes 8, 9, and 21, and identified a masked type of variant t(8;21)(q22;q22) translocation. The karyotype was finally determined as 45,X,-Y,der(8) t(8;21)(q22;q22), der(9)(8;9) (q22;q34), and der(21) t(9;21)(q34;q22). Results of FISH using the AML1/ETO probe and detection of the AML1/ETO fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) support the karyotype as well as the sequence of the PCR product. Additionally, C-KIT mutation was detected.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 18 条
[1]   Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22) [J].
Baer, MR ;
Stewart, CC ;
Lawrence, D ;
Arthur, DC ;
Byrd, JC ;
Davey, FR ;
Schiffer, CA ;
Bloomfield, CD .
BLOOD, 1997, 90 (04) :1643-1648
[2]   PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :620-625
[3]  
Bloomfield CD, 1998, CANCER RES, V58, P4173
[4]   Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study [J].
Cairoli, R ;
Beghini, A ;
Grillo, G ;
Nadali, G ;
Elice, F ;
Ripamonti, CB ;
Colapietro, P ;
Nichelatti, M ;
Pezzetti, L ;
Lunghi, M ;
Cuneo, A ;
Viola, A ;
Ferrara, F ;
Lazzarino, M ;
Rodeghiero, F ;
Pizzolo, G ;
Larizza, L ;
Morra, E .
BLOOD, 2006, 107 (09) :3463-3468
[5]   Molecular basis of the constitutive activity and ST1571 resistance of Asp816Val mutant KIT receptor tyrosine kinase [J].
Foster, R ;
Griffith, R ;
Ferrao, P ;
Ashman, L .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2004, 23 (02) :139-152
[6]   VARIANT T(821) REARRANGEMENTS IN ACUTE MYELOBLASTIC-LEUKEMIA OF CHILDHOOD [J].
GALLEGO, M ;
CARROLL, AJ ;
GAD, GS ;
PAPPO, A ;
HEAD, D ;
BEHM, F ;
RAVINDRANATH, Y ;
RAIMONDI, SC .
CANCER GENETICS AND CYTOGENETICS, 1994, 75 (02) :139-144
[7]  
KITA K, 1992, BLOOD, V80, P470
[8]   AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation [J].
Miyamoto, T ;
Weissman, IL ;
Akashi, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7521-7526
[9]   THE T(8-21) TRANSLOCATION IN ACUTE MYELOID-LEUKEMIA RESULTS IN PRODUCTION OF AN AML1-MTG8 FUSION TRANSCRIPT [J].
MIYOSHI, H ;
KOZU, T ;
SHIMIZU, K ;
ENOMOTO, K ;
MASEKI, N ;
KANEKO, Y ;
KAMADA, N ;
OHKI, M .
EMBO JOURNAL, 1993, 12 (07) :2715-2721
[10]   Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene [J].
Monma, F ;
Nishii, K ;
Yamamori, S ;
Hosokai, N ;
Nakazaki, T ;
Lorenzo, F ;
Usui, E ;
Sakakura, M ;
Miyashita, H ;
Fujieda, A ;
Ohishi, K ;
Katayama, N ;
Shiku, H .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (02) :155-158